865
Participants
Start Date
December 31, 2008
Primary Completion Date
June 30, 2013
Study Completion Date
December 31, 2013
rifampin
tablet, 10 mg/kg, daily, 8 weeks
rifapentine
tablet, 10 mg/kg, daily, 8 weeks
rifapentine
tablet, 15 mg/kg, daily, 8 weeks
rifapentine
20 mg/kg, daily, 8 weeks
Columbia University/Presbyterian Medical Center, New York
Harlem Hospital, Columbia University, New York
Washington DC Veterans Administration Medical Center, Washington D.C.
Johns Hopkins University School of Medicine, Baltimore
Duke University Medical Center, Durham
Emory University School of Medicine, Atlanta
Veterans Administration Tennessee Valley Health Care System, Nashville
Hines VA Medical Center, Hines
Chicago VA Medical Center (Lakeside), Chicago
Northwestern University, Chicago
Central Arkansas Veterans Health System, Little Rock
University of North Texas Health Science Center, Fort Worth
Houston Veterans Administration Medical Center, Houston
Audi L. Murphy VA Hospital, San Antonio
Denver Department of Public Health and Hospitals, Denver
LA County/USC Medical Center, Los Angeles
University of Southern California Medical Center, Los Angeles
University of California at San Diego, San Diego
University of California, San Francincisco, San Francisco
Seattle King County Health Department, Seattle
Boston Medical Center, Boston
New Jersey Medical School, Newark
Nashville VA Medical Center, Nashville
Hopital Universitario Clementino Fraga Filho, Rio de Janeiro
University of Manitoba, Winnepeg
Montreal Chest Institute McGill University, Montreal
Nelson R Mandela School of Medicine, Durban
Makerere University Medical School, Kampala
Agencia de Salut Publica, Barcelona
Collaborators (1)
Sanofi
INDUSTRY
Centers for Disease Control and Prevention
FED